Investigating Brain Function in People With and Without Visual Snow Syndrome Using Adaptation to Visual Stimuli
University of Minnesota · with National Institutes of Health (NIH), Mayo Clinic · NCT06961864
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–60 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 100
- US sites recruiting
- 1
- Study start
- April 11, 2025
- Record last updated
- January 14, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The goal of this study is to learn more about the brain pathways and activity involved in creating Visual Snow Syndrome (VSS). The main questions it aims to answer are:
- Does VSS arise from spontaneous activity in brain pathways?
- Where in the brain does the activity contributing to VSS arise?
- How does brain activity contribute to VSS?
Participants will
- Undergo assessments and questionnaires to understand visual and mental symptoms, cognitive, and sensory function.
- Make visual judgements based on images presented to them both inside and outside a magnetic resonance imaging (MRI) machine.
- Undergo scanning of their brain while inside of an MRI machine.
Being studied: Visual Adaptation; Assessments and Questionnaires; Functional Magnetic Resonance Imaging (fMRI); Magnetic Resonance Imaging (MRS)
Conditions: Visual Snow Syndrome; Migraine; Healthy
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria for People with Visual Snow Syndrome:
- Between the ages of 18 and 60 years old
- Normal (20/25 or better in each eye) or corrected-to-normal vision (MR-compatible glasses will be provided as needed)
- Ability to comply with study instructions
- Individuals who have a current diagnosis of VSS from a neuro-ophthalmologist or meet diagnostic criteria of VSS (experience of dynamic dots across the visual field persisting longer than 3 months and at least 2 of the following additional visual symptoms: palinopsia, entoptic phenomena, trails behind moving objects, photophobia, or nyctalopia)
- Individuals living in Minnesota within 2 hours of the study site
Inclusion Criteria for Non-snow Controls
- Between the ages of 18 and 60 years old
- Normal (20/25 or better in each eye) or corrected-to-normal vision (MR-compatible glasses will be provided as needed)
- Ability to comply with study instructions
- Individuals living in Minnesota within 2 hours of the study site
Exclusion Criteria for People with Visual Snow Syndrome:
- Not being fluent in English or another language for which interpretation/translation services are available
- A diagnosed or self-reported intellectual disability
- Current substance dependence (besides nicotine), or drug dependence with tolerance or withdrawal within past 12 months
- Hallucinogenic substance use within the past 12 months or hallucinogenic substance use within 12 months prior to onset of VSS symptoms
- Severe central nervous system disease
- Head injury with skull fracture or loss of consciousness for more than thirty minutes
- Presence of a physical problem that would render study measures difficult or impossible to administer or interpret (e.g., visual field loss)
- Age less than 18 years or greater than 60 years
- MRI exclusions (for MR visits only):
- Metal in the body that cannot be approved by the CMRR safety committee
- Pregnancy
- Conditions that affect neuro-hemodynamic coupling
- Claustrophobia
- Inability to lie still for at least an hour
- Weight in excess of 440 lbs
- CT scan exclusion only: Research-related radiation exposure within the last 12 months
- Any vision anomaly aside from VS or refractive error (e.g., strabismus/ crossed eyes, lazy eyes, color blindness)
- Current psychotic episode
Exclusion Criteria for Non-snow Controls
- Not being fluent in English or another language for which interpretation/translation services are available
- A diagnosed or self-reported intellectual disability
- Current substance dependence (besides nicotine), or drug dependence with tolerance or withdrawal within past 12 months
- Hallucinogenic substance use within the past 12 months
- Severe central nervous system disease
- Head injury with skull fracture or loss of consciousness for more than thirty minutes
- Presence of a physical problem that would render study measures difficult or impossible to administer or interpret (e.g., visual field loss)
- Age less than 18 years or greater than 60 years
- MRI exclusions (for MR visits only):
- Metal in the body that cannot be approved by the CMRR safety committee
- Pregnancy
- Conditions that affect neuro-hemodynamic coupling
- Claustrophobia
- Inability to lie still for at least an hour
- Weight in excess of 440 lbs
- CT scan exclusion only: Research-related radiation exposure within the last 12 months
- Any vision anomaly or refractive error (e.g. strabismus/ crossed eyes, lazy eyes, color blind)
- A personal history of VSS symptoms or a diagnosis with VSS
- Current psychotic episode
Recruiting US locations
University of Minnesota
Minneapolis, MN 55455
Site contact: Michael-Paul Schallmo, Ph.D., Assistant Professor · 612-273-9130 · schallmolab@umn.edu
Study contacts (from the official record)
- Michael-Paul Schallmo, Ph.D. · (612) 273-9130 · schallmolab@umn.edu
- Hannah Moser, Ph.D. · schallmolab@umn.edu
Similar studies in Minnesota
All neurology studies in Minnesota →- RecruitingHealthy volunteersPhase 1
Safety, Tolerability, and Pharmacokinetics of ASCT-83 in Healthy Adults
Alcamena Stem Cell Therapeutics
- Location
- Saint Paul, MN
- Eligibility basics
- Ages 18–64
- RecruitingHealthy volunteersPhase 1
Microelectrode Recordings From the Vagus Nerve in Awake Humans
University of Minnesota
- Location
- Minneapolis, MN
- Eligibility basics
- Ages 18–40
- RecruitingHealthy volunteersEarly Phase 1
Stimulating After Recovery From Traumatic Brain Injury
University of Minnesota
- Location
- Minneapolis, MN
- Eligibility basics
- Ages 18+
- RecruitingPhase 1/Phase 2
A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome
Encoded Therapeutics
- Location
- Rochester, MN + 9 other US sites
- Eligibility basics
- Ages 6 mo–17